A p18 mutant defective in CDK6 binding in human breast cancer cells

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4586-4589

  Lapointe, Jacques ^a   Lachance, Yves ^a   Labrie, Yvan ^a   Labrie, Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL CYCLE; CELL CYCLE S PHASE; CHROMOSOME 1; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; GENES, TUMOR SUPPRESSOR; GLUTATHIONE TRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0029795614     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995
2. MacLachlan, T K., Sang, N , and Giordano, A Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Clin. Rev. Eukaryotic Gene Expression, 5: 127-156, 1995.
3. Guan, K-L , Jenkins, C. W , Li Y , Nichols, M A., Wu, X , O'Keefe, C L , Matera, A. G , and Xiong, Y. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/ MTS2-reiated CDK6 inhibitor, correlates with wild-type pRb function Genes Dev., 8: 2939-2952, 1994
4. Aprelikova, O , Xiong, Y , and Liu, E T. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol Chem, 270: 18195-18197, 1995
5. Kamb, A , Gruis, N A., Weaver-Feldhaus, J., Liu, Q , Harshman, K., Tavtigian, S V., Stocken, E., Day, R. S , III, Johnson, B E , and Skolnick, M. H A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994
6. Nobori, T , Miura, K., Wu, D J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond ), 368. 753-756, 1994.
7. Caldas, C , Hahn, S. A , da Costa, L T., Redston, M. S., Schutte, M , Seymour, A. B., Weinstein, C. L., Hruban, R H , Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet , 8: 27-32, 1994
8. Merlo, A , Herman, J G , Mao, L , Lee, D. J , Gabrielson, E., Burger, P. C., Baylin, S. B , and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1. 686-692, 1995.
9. Ranade, K , Hussussian, C J , Sikorski, R. S , Varmus, H. E , Goldstein, A. M., Tucker, M. A., Serrano, M , Hannon, G J., Beach, D., and Dracopoli, N C. Mutations associated with familial melanoma impair p 16INK4 function. Nat Genet. 10: 114-116, 1995.
10. Hainsworth, P J , Raphael, K. L , Stillwell, R. G , Bennett, R C., and Garson, O. M. Cytogenetic features of twenty-six primary breast cancers. Cancer Genet. Cytogenet , 52 205-218, 1991
11. Blèche, I., Champème, M-H., and Lidereau, R. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer. Cancer Res., 54: 4274-4276, 1994.
12. Koduru, P R , Zariwala, M., Soni, M., Gong, J Z , Xiong, Y , and Broome, J D. Deletion of cyclin-dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood, 86: 2900-2905, 1995.
13. INK4B/ MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res , 55. 1448-1451, 1995.
14. Takeuchi, S., Bartram, C. R., Seriu, T., Miller, C. W., Tobler, A , Janssen, J. W. G , Reiter, A., Ludwig, W-D , Zimmermann, M , Schwaller, J., Lee, E., Miyoshi, I., and Koeffler, H P Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/ INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood Blood, 86. 755-760, 1995.
15. Zariwala, M , Liu, E , and Xiong, Y Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors. Oncogene, 72: 451-455, 1996.
16. Rhéaume, E , Simard, J , Morel, Y , Mebarki, F., Zachmann, M , Forest, M. G., New, M I , and Labrie, F Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene Nat. Genet , 1: 239-245, 1992.
17. Frangioni, J. V., and Neel, B. G. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins Anal Biochem., 210: 179-187, 1993.
18. Wolfel, T., Hauer, M., Schneider, J , Serrano, M , Wolfel, C , Klehmann-Hieb, E., De Plaen, E , Hankeln, T , Meyer zum Buschenfelde, K-H., and Beach, D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science (Washington DC), 269: 1281-1284, 1995
19. Qin, X-Q., Chittenden, T., Livingston, D. M., and Kaelin, W G., Jr. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev , 6: 953-964, 1992
20. T'Ang, A., Varley, J. M., Chakraborty, S , Murphree, A L , and Fung, Y-K T Structural rearrangement of the retinoblastoma gene in human breast carcinoma Science (Washington DC), 242 263-266, 1988
21. Serrano, M., Hannon, G. J , and Beach, D A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond ), 366: 704-707, 1994.
22. Koh, J , Enders, G H., Dynlacht, B D., and Harlow, E Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition Nature (Lond.), 375: 506-510, 1995.
23. Lukas, J , Parry, D , Aagaard, L , Mann, D. J., Bartkova, J , Strauss, M , Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature (Lond ), 375. 503-506, 1995
24. Hall, M., Bates, S , and Peters, G Evidence for different modes of action of cyclin-dependent kinase inhibitors p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene, 11 1581-1588, 1995